Hemophilia patient demographics
| Patient no. . | Clinical details . | Age, y . | FVIII/FIX, IU/dL . | APTT ratio . | Fibrinogen, mg/mL . | Platelets, × 109/mL . |
|---|---|---|---|---|---|---|
| 1 | Severe A | 22 | < 1.0 | 2.25 | 2.53 | 237 |
| 2 | Severe A | 27 | < 1.0 | 2.30 | 2.22 | 203 |
| 3 | Severe A | 30 | < 1.0 | 1.90 | 2.58 | 268 |
| 4 | Mild A | 46 | 7.6 | 1.84 | 3.88 | 182 |
| 5 | Severe A | 22 | < 1.0 | 2.10 | 2.70 | 170 |
| 6 | Severe A | 32 | < 1.0 | 2.14 | 2.79 | 173 |
| 7 | Severe A | 27 | 1.2 | 1.86 | 2.62 | 210 |
| 8 | Severe B | 58 | 5.8 | 1.33 | 3.33 | 192 |
| 9 | Severe A | 23 | < 1 | 1.78 | 2.57 | 136 |
| 10 | Severe A | 29 | 1.1 | 2.10 | 3.04 | 237 |
| 11 | Moderate A | 51 | 57.9 | 1.17 | 2.64 | 208 |
| 12 | Moderate A | 35 | 3.8 | 1.81 | 3.36 | 217 |
| 13 | Severe B | 34 | 1.6 | 2.00 | 2.10 | 108 |
| 14 | Severe A | 37 | < 1 | 2.17 | 2.53 | 179 |
| 15 | Severe A | 25 | < 1 | 2.35 | 2.62 | 228 |
| 16 | Severe A | 23 | < 1 | 2.33 | 2.43 | 170 |
| 17 | Severe A | 28 | < 1 | 2.30 | 2.10 | 139 |
| Patient no. . | Clinical details . | Age, y . | FVIII/FIX, IU/dL . | APTT ratio . | Fibrinogen, mg/mL . | Platelets, × 109/mL . |
|---|---|---|---|---|---|---|
| 1 | Severe A | 22 | < 1.0 | 2.25 | 2.53 | 237 |
| 2 | Severe A | 27 | < 1.0 | 2.30 | 2.22 | 203 |
| 3 | Severe A | 30 | < 1.0 | 1.90 | 2.58 | 268 |
| 4 | Mild A | 46 | 7.6 | 1.84 | 3.88 | 182 |
| 5 | Severe A | 22 | < 1.0 | 2.10 | 2.70 | 170 |
| 6 | Severe A | 32 | < 1.0 | 2.14 | 2.79 | 173 |
| 7 | Severe A | 27 | 1.2 | 1.86 | 2.62 | 210 |
| 8 | Severe B | 58 | 5.8 | 1.33 | 3.33 | 192 |
| 9 | Severe A | 23 | < 1 | 1.78 | 2.57 | 136 |
| 10 | Severe A | 29 | 1.1 | 2.10 | 3.04 | 237 |
| 11 | Moderate A | 51 | 57.9 | 1.17 | 2.64 | 208 |
| 12 | Moderate A | 35 | 3.8 | 1.81 | 3.36 | 217 |
| 13 | Severe B | 34 | 1.6 | 2.00 | 2.10 | 108 |
| 14 | Severe A | 37 | < 1 | 2.17 | 2.53 | 179 |
| 15 | Severe A | 25 | < 1 | 2.35 | 2.62 | 228 |
| 16 | Severe A | 23 | < 1 | 2.33 | 2.43 | 170 |
| 17 | Severe A | 28 | < 1 | 2.30 | 2.10 | 139 |
APTT indicates activated partial thromboplastin time.